Navigation Links
CareFusion Corp to be Included in S&P 500 Index
Date:8/25/2009

SAN DIEGO, Aug. 25 /PRNewswire-FirstCall/ -- CareFusion Corporation announced today that its stock will be included in the S&P 500 index following the company's planned spinoff from Cardinal Health on Aug. 31. CareFusion stock will be added to the index on Sept. 1, coinciding with its first day of regular-way trading on the New York Stock Exchange under the symbol "CFN."

"Our inclusion in the S&P 500 is a testament to our position in the industry as we launch a new public company dedicated to helping hospitals improve patient care and safety, both domestically and around the world," said David Schlotterbeck, chief executive officer of CareFusion. "We are pleased to be recognized among such a select group of U.S. companies."

CareFusion provides products and services designed to help measurably improve patient care in two major areas: medication errors and hospital-acquired infections. The company's common stock began trading on a "when issued" basis on Aug. 21. On Aug. 31, "when issued" trading is scheduled to end and "regular way" trading is scheduled to begin on Sept. 1 under the ticker symbol "CFN."

Regarded as one of the best single gauges of the U.S. equities market, the S&P 500 index includes 500 leading companies in leading industries of the U.S. economy.

About CareFusion Corporation

CareFusion Corporation is currently a wholly owned subsidiary of Cardinal Health (NYSE: CAH). The global company serves the health care industry with products and services that help hospitals measurably improve the safety and quality of care. CareFusion develops market-leading technologies including Alaris(R) IV pumps, Pyxis(R) automated dispensing and patient identification systems, AVEA(R) and Pulmonetic Systems(TM) ventilation and respiratory products, ChloraPrep(R) for infection prevention and MedMined(TM) services for infection surveillance, neurological monitoring and diagnostic products, V. Mueller(R) surgical instruments and an extensive line of products that support interventional medicine.

CareFusion employs more than 15,000 people across its global operations. The company has been authorized to have its shares of common stock listed on the New York Stock Exchange under the ticker symbol "CFN." More information may be found at carefusion.com.

Cautions concerning forward-looking statements

This news release contains forward-looking statements addressing the planned spinoff of the clinical and medical products businesses of Cardinal Health as a separate company named CareFusion Corporation, which is dependent upon future events or developments. These matters are subject to risks and uncertainties that could cause actual events (including the planned spinoff) and results to differ materially from those projected, anticipated or implied. These risks and uncertainties include uncertainties regarding the planned spinoff of CareFusion, including the timing and terms of such spinoff and whether such spinoff will be completed as it is subject to a number of conditions. In addition, Cardinal Health and CareFusion are subject to additional risks and uncertainties described in CareFusion's Form 10, as amended, and Cardinal Health's Form 10-K, Form 10-Q and Form 8-K reports (including all amendments to those reports) and exhibits to those filings and reports. Except to the extent required by applicable law, Cardinal Health and CareFusion undertake no obligation to update or revise any forward-looking statement.


'/>"/>
SOURCE CareFusion Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. CareFusion Issues Update Regarding Previously Disclosed June 12, 2009 Recall of the Alaris(R) System
2. CareFusion Form 10 Registration Statement Declared Effective
3. CareFusion Expands Pyxis(R) Perioperative Solutions Offering
4. CareFusion Prices $1.4 Billion of Senior Notes
5. Cardinal Health Board of Directors Approves CareFusion Spinoff
6. CareFusion to Resume Shipping Alaris(R) Infusion Products
7. CareFusion Corporation Launches International Jazz Festival Series
8. CareFusion Files Amended Form 10 Registration Statement With SEC
9. CareFusion Launches New Brand, Establishing Itself as an Industry Leader in Helping Hospitals Improve Patient Care and Safety
10. CareFusion Names Robert Friel to Board of Directors
11. CareFusion Announces Board of Directors, Progress on Alaris Consent Decree
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... Medforce Technologies, a leading ... the only electronic signature tool built specifically for the healthcare industry by a ... in the modern healthcare company: obtaining signatures from a wide variety of individuals ...
(Date:2/28/2017)... Gowrie, IA (PRWEB) , ... February 28, 2017 , ... Webster-Calhoun Cooperative Telephone Association ... cooperative to be held on Tuesday, March 14th at 7:00 pm at the Southeast Valley ... is "Set Your Sights For Great Service" What do you look for in ...
(Date:2/28/2017)... ... February 28, 2017 , ... Today, Bright Pink , a national ... empowering young women to live proactively at a young age. 1 in 8 ... cancer. Prevention and early detection can save lives-but only if young women are proactive ...
(Date:2/28/2017)... ... February 28, 2017 , ... The American Academy of ... scientific development, healthcare training and clinical application of medical infrared imaging, has announced ... 16-17 in Greenville, SC at the Bon Secours St. Francis Hospital campus at ...
(Date:2/28/2017)... , ... February 28, 2017 , ... ... Institute (HCI) announced a new partnership through which HCI students, faculty, and ... curriculum and practices. The partnership also enables the HCI community to receive educational ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... February 28, 2017 The ... rendered the vendor landscape of the  Global Lap ... exhibits a high degree of consolidation with the ... the overall market in 2016. Among these enterprises ... and Abbott Laboratories enjoy dominance on account of ...
(Date:2/28/2017)... Calif., Feb. 28, 2017  Ionis Pharmaceuticals, Inc. (Nasdaq: ... its financial guidance by ending 2016 with pro forma ... cash, cash equivalents and short-term investments. The Company also ... "2016 was a year of significant accomplishments ... in record time and with a very broad label. ...
(Date:2/28/2017)... 28, 2017 ... Research and Markets has announced the addition of the ... to their offering. The latest research Ovarian Cancer Drugs ... in the global Ovarian Cancer market. The research answers the ... marketed for Ovarian Cancer and their clinical attributes? How are they positioned ...
Breaking Medicine Technology: